文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于粪便免疫化学试验的筛查方案中,阴性结肠镜检查后的结肠镜检查间期结直肠癌。

Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program.

机构信息

Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

出版信息

Endoscopy. 2023 Dec;55(12):1061-1069. doi: 10.1055/a-2136-6564. Epub 2023 Oct 4.


DOI:10.1055/a-2136-6564
PMID:37793423
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10684335/
Abstract

BACKGROUND: In the Dutch colorectal (CRC) screening program, fecal immunochemical test (FIT)-positive individuals are referred for colonoscopy. If no relevant findings are detected at colonoscopy, individuals are reinvited for FIT screening after 10 years. We aimed to assess CRC risk after a negative colonoscopy in FIT-positive individuals. METHODS: In this cross-sectional cohort study, data were extracted from the Dutch national screening information system. Participants with a positive FIT followed by a negative colonoscopy between 2014 and 2018 were included. A negative colonoscopy was defined as a colonoscopy during which no more than one nonvillous, nonproximal adenoma < 10 mm or serrated polyp < 10 mm was found. The main outcome was interval post-colonoscopy CRC (iPCCRC) risk. iPCCRC risk was reviewed against the risk of interval CRC after a negative FIT (FIT IC) with a 2-year screening interval. RESULTS: 35 052 FIT-positive participants had a negative colonoscopy and 24 iPCCRCs were diagnosed, resulting in an iPCCRC risk of 6.85 (95 %CI 4.60-10.19) per 10 000 individuals after a median follow-up of 1.4 years. After 2.5 years of follow-up, age-adjusted iPCCRC risk was approximately equal to FIT IC risk at 2 years. CONCLUSION: Risk of iPCCRC within a FIT-based CRC screening program was low during the first years after colonos-copy but, after 2.5 years, was the same as the risk in FIT-negative individuals at 2 years, when they are reinvited for screening. Colonoscopy quality may therefore require further improvement and FIT screening interval may need to be reduced after negative colonoscopy.

摘要

背景:在荷兰结直肠癌(CRC)筛查计划中,粪便免疫化学测试(FIT)阳性者将被转介进行结肠镜检查。如果结肠镜检查未发现相关发现,将在 10 年后再次邀请这些人进行 FIT 筛查。我们旨在评估 FIT 阳性者结肠镜检查阴性后的 CRC 风险。

方法:在这项横断面队列研究中,数据从荷兰国家筛查信息系统中提取。纳入 2014 年至 2018 年间进行阳性 FIT 检查后阴性结肠镜检查的参与者。阴性结肠镜检查定义为结肠镜检查期间仅发现不超过一个非绒毛、非近端腺瘤<10mm 或锯齿状息肉<10mm。主要结局是结肠镜检查后间隔期 CRC(iPCCRC)风险。使用 2 年筛查间隔的阴性 FIT(FIT IC)后的间隔 CRC 风险来审查 iPCCRC 风险。

结果:35052 名 FIT 阳性者进行了阴性结肠镜检查,诊断出 24 例 iPCCRC,在中位随访 1.4 年后,每 10000 人中发生 iPCCRC 的风险为 6.85(95%CI 4.60-10.19)。随访 2.5 年后,年龄调整后的 iPCCRC 风险与 2 年时的 FIT IC 风险大致相同。

结论:在基于 FIT 的 CRC 筛查计划中,结肠镜检查后最初几年内 iPCCRC 的风险较低,但 2.5 年后,与 2 年时再次邀请进行筛查的 FIT 阴性者的风险相同。因此,结肠镜检查质量可能需要进一步提高,并且在阴性结肠镜检查后 FIT 筛查间隔可能需要缩短。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4b/10684335/20a2bc3afd32/10-1055-a-2136-6564-i22404en2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4b/10684335/307d147a2d91/10-1055-a-2136-6564-i22404en1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4b/10684335/20a2bc3afd32/10-1055-a-2136-6564-i22404en2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4b/10684335/307d147a2d91/10-1055-a-2136-6564-i22404en1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e4b/10684335/20a2bc3afd32/10-1055-a-2136-6564-i22404en2.jpg

相似文献

[1]
Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program.

Endoscopy. 2023-12

[2]
The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.

BMC Cancer. 2022-12-12

[3]
Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test.

J Med Screen. 2022-9

[4]
Multiple Negative Fecal Immunochemical Tests Reduce Risk of Advanced Neoplasia in a Colonoscopy Surveillance Program.

Clin Gastroenterol Hepatol. 2023-8

[5]
Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.

Gastroenterology. 2017-5-5

[6]
Factors associated with interval colorectal cancer after negative FIT: Results of two screening rounds in the Dutch FIT-based CRC screening program.

Int J Cancer. 2023-4-15

[7]
Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.

Ann Intern Med. 2017-10-3

[8]
Clinical Features of Fecal Immunochemical Test-Negative Colorectal Lesions based on Colorectal Cancer Screening among Asymptomatic Participants in Their 50s.

Asian Pac J Cancer Prev. 2022-7-1

[9]
Diagnostic Yield of One-Time Colonoscopy vs One-Time Flexible Sigmoidoscopy vs Multiple Rounds of Mailed Fecal Immunohistochemical Tests in Colorectal Cancer Screening.

Clin Gastroenterol Hepatol. 2020-3

[10]
Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.

Gut. 2021-7

引用本文的文献

[1]
Texture and Color Enhanced Imaging in the Diagnosis of Colonic Neoplasia: A Systematic Review and Analysis.

JGH Open. 2025-8-17

[2]
Screening outcomes at second FIT screening in individuals with a first time negative FIT-result or low-risk adenomas: Results from a nationwide FIT screening program.

Int J Cancer. 2025-8-15

[3]
Stool and blood biomarkers for colorectal cancer management: an update on screening and disease monitoring.

Mol Cancer. 2024-11-19

本文引用的文献

[1]
Adenoma Detection Rate and Risk for Interval Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test-Based Screening : A Population-Based Cohort Study.

Ann Intern Med. 2022-10

[2]
Serrated polyp detection and risk of interval post-colonoscopy colorectal cancer: a population-based study.

Lancet Gastroenterol Hepatol. 2022-8

[3]
Analysis of Post-Colonoscopy Colorectal Cancer and Its Subtypes in a Screening Programme.

Cancers (Basel). 2021-10-12

[4]
Optimal cut-off value for detecting colorectal cancer with fecal immunochemical tests according to age and sex.

PLoS One. 2021

[5]
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

CA Cancer J Clin. 2021-5

[6]
Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.

Gut. 2021-7

[7]
Long-Term Colorectal Cancer Incidence and Mortality After a Single Negative Screening Colonoscopy.

Ann Intern Med. 2020-5-26

[8]
Incidence of Interval Colorectal Cancer After Negative Results From First-Round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age.

Clin Gastroenterol Hepatol. 2020-6

[9]
Quality Monitoring of a FIT-Based Colorectal Cancer Screening Program.

Clin Chem. 2019-1-16

[10]
Long-term Risk of Colorectal Cancer and Related Deaths After a Colonoscopy With Normal Findings.

JAMA Intern Med. 2019-2-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索